Daily Archives: September 2, 2014

Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke

BARCELONA, Spain, Sept. 3, 2014 /PRNewswire/ — — GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients at risk of stroke in everyday clinical…

American Green Technology(R) Installs HRMS Technology in Plastic Surgery Clinic in Malaysia

SOUTH BEND, Indiana, September 2, 2014 /PRNewswire/ — American Green Technology® (AGT) has installed their innovative Health Risk Management System (HRMS) in a plastic surgery center in Kuala Lumpur, Malaysia.…

Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan — Emerging technologies will include ‘smaller than a fingernail’ nanopatch vaccines

LONDON, Sept. 2, 2014  /PRNewswire/ — Drug delivery technologies that improve access and overall efficacy are becoming an essential part of the entire drug development process. Pharmaceutical companies are particularly investing billions…

RVX-208 Leads to a 77% Relative Risk Reduction of Major Adverse Cardiovascular Events (MACE) in Patients with Diabetes Mellitus

Presented in ‘State of the Art and Featured Research Session’ at the 2014 European Society of Cardiology Congress TSX Exchange Symbol: RVX BARCELONA, Spain and CALGARY, AB, Sept. 2, 2014…

Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors

— Novilase minimizes the loss of surrounding breast tissues and reduces retreatment rates MOUNTAIN VIEW, Calif., Sept. 2, 2014 /PRNewswire/ — Based on its recent analysis of the early-stage breast tumor…

GC-Rise Closes US$15 Million Series B Financing

BEIJING, September 2, 2014 /PRNewswire/ — GC-Rise Pharmaceutical Co. Ltd (Company), a leading pharmaceutical company focused on women and children’s healthcare, announced that it has closed a US$15 million Series…

Sinovac to Participate in Upcoming Investor Conferences

BEIJING, September 2, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate in the following…

DXY to Receive US$70 Million from Tencent

BEIJING, Sept. 2, 2014 /PRNewswire/ — Ting Ting Group ("DXY"), the largest online healthcare service community in China, today announces that it will receive a strategic investment of US$70 million…

Frost & Sullivan Presents Goodwin Biotechnology with the Global Customer Value Leadership Award for Mammalian Biologics Contract Manufacturing

— Goodwin Biotechnology pioneered best-in-class practices for the development of complex Biopharmaceuticals and Antibody Drug Conjugates (ADCs) LONDON, Sept. 2, 2014 /PRNewswire/ — Based on its recent analysis of the…